Cell Discovery

Nature Publishing Group

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Cell Discovery is an open-access journal published by Nature Publishing Group in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,090 EUR. Declared review time at DOAJ: 20 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Nature Publishing Group
ISSN
2056-5968
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
3,090 EUR
Articles in DOAJ
697
Declared review time
20 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2015-08-25
  • PUBMED · 2020-10-29
Indexing
DOAJ · PUBMED
APC
3,090 EUR
Declared review time (DOAJ)
20 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

697

Most recent article

last month

Average review time (journal-declared via DOAJ)

20weeks

Works in OpenAlex

1060

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

99

i10-index

786

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-17
Added to DOAJ
2015-08-25
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
PMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
95%
ORCID iDs in current deposits
92%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101661034
Classification2

Subjects (DOAJ)

Science: Biology (General): Cytology

LCC codes

QH573-671

Subject areas

  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 and COVID-19 Research
  • RNA modifications and cancer
  • RNA modifications and cancer
  • CRISPR and Genetic Engineering
  • CRISPR and Genetic Engineering
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
Show all subjects (50)
  • RNA Research and Splicing
  • RNA Research and Splicing
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
  • Single-cell and spatial transcriptomics
  • Single-cell and spatial transcriptomics
  • Genomics and Chromatin Dynamics
  • Genomics and Chromatin Dynamics
  • RNA and protein synthesis mechanisms
  • RNA and protein synthesis mechanisms
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Ubiquitin and proteasome pathways
  • Receptor Mechanisms and Signaling
  • Ubiquitin and proteasome pathways
  • Receptor Mechanisms and Signaling
  • Pluripotent Stem Cells Research
  • Pluripotent Stem Cells Research
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Endoplasmic Reticulum Stress and Disease
  • Cancer-related gene regulation
  • Immune cells in cancer
  • Cancer-related gene regulation
  • Immune cells in cancer
  • Endoplasmic Reticulum Stress and Disease
  • RNA regulation and disease
  • RNA regulation and disease
  • interferon and immune responses
  • interferon and immune responses
  • Autophagy in Disease and Therapy
  • Autophagy in Disease and Therapy
  • DNA Repair Mechanisms
  • DNA Repair Mechanisms
  • Cancer Immunotherapy and Biomarkers
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Cancer Immunotherapy and Biomarkers
  • Virus-based gene therapy research
  • Microtubule and mitosis dynamics
  • Virus-based gene therapy research
  • Microtubule and mitosis dynamics

Keywords (DOAJ)

  • cell growth and differentiation
  • signal transduction
  • apoptosis
  • stem cells
  • immunology
  • cell development

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: